These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
57 related articles for article (PubMed ID: 5043227)
1. Metabolic studies in man with mycophenolic acid (NSC-129185), a new antitumor agent. Lintrup J; Hyltoft-Petersen P; Knudtzon S; Nissen NI Cancer Chemother Rep; 1972 Apr; 56(2):229-35. PubMed ID: 5043227 [No Abstract] [Full Text] [Related]
2. Clinical trial with mycophenolic acid (NSC-129185), a new antitumor agent. Knudtzon S; Nissen NI Cancer Chemother Rep; 1972 Apr; 56(2):221-7. PubMed ID: 4557737 [No Abstract] [Full Text] [Related]
3. Effect of acidification on protein binding of mycophenolic acid. Ting LS; Decarie D; Ensom MH Ther Drug Monit; 2007 Feb; 29(1):132-3. PubMed ID: 17304164 [No Abstract] [Full Text] [Related]
4. The metabolism and binding of ( 14 C)mycophenolic acid in the rat. Nery R; Nice E J Pharm Pharmacol; 1971 Nov; 23(11):842-7. PubMed ID: 4400192 [No Abstract] [Full Text] [Related]
6. The disposition of the antitumor agent, sangivamycin, in mice. Hardesty CT; Chaney NA; Waravdekar VS; Mead JA Cancer Res; 1974 May; 34(5):1005-9. PubMed ID: 4823899 [No Abstract] [Full Text] [Related]
7. Pharmacokinetic profile of mycophenolic acid in piglets after small bowel transplantation. Iacona I; Regazzi MB; Spada M; Villani P; Molinaro M; Alessiani M Transplant Proc; 1996 Oct; 28(5):2525-6. PubMed ID: 8907934 [No Abstract] [Full Text] [Related]
8. Experimental antitumor activity and preclinical toxicology of mycophenolic acid. Sweeney MJ; Gerzon K; Harris PN; Holmes RE; Poore GA; Williams RH Cancer Res; 1972 Sep; 32(9):1795-802. PubMed ID: 4509039 [No Abstract] [Full Text] [Related]
9. Glucuronidation associated with intrinsic resistance to mycophenolic acid in human colorectal carcinoma cells. Franklin TJ; Jacobs V; Jones G; Plé P; Bruneau P Cancer Res; 1996 Mar; 56(5):984-7. PubMed ID: 8640790 [TBL] [Abstract][Full Text] [Related]
10. Concentrations of mycophenolic acid and glucuronide metabolites under concomitant therapy with cyclosporine or tacrolimus. Patel CG; Harmon M; Gohh RY; Akhlaghi F Ther Drug Monit; 2007 Feb; 29(1):87-95. PubMed ID: 17304155 [TBL] [Abstract][Full Text] [Related]
11. A new antitumor antibiotic, carminomycin (NSC-180024). Gause GF; Brazhnikova MG; Shorin VA Cancer Chemother Rep; 1974; 58(2):255-6. PubMed ID: 4830498 [No Abstract] [Full Text] [Related]
12. Pharmacological and biochemical effects of pyrazofurin in humans. Ohnuma T; Roboz J; Shapiro ML; Holland JF Cancer Res; 1977 Jul; 37(7 Pt 1):2043-9. PubMed ID: 861933 [No Abstract] [Full Text] [Related]
13. Metabolism and biochemistry of mycophenolic acid. Sweeney MJ; Hoffman DH; Esterman MA Cancer Res; 1972 Sep; 32(9):1803-9. PubMed ID: 4629779 [No Abstract] [Full Text] [Related]
14. Sensitive high-performance liquid chromatography-tandem mass spectrometry method for quantitative analysis of mycophenolic acid and its glucuronide metabolites in human plasma and urine. Benoit-Biancamano MO; Caron P; Lévesque E; Delage R; Couture F; Guillemette C J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):159-67. PubMed ID: 17827076 [TBL] [Abstract][Full Text] [Related]
15. Human colorectal carcinoma cells in vitro as a means to assess the metabolism of analogs of mycophenolic acid. Franklin TJ; Jacobs VN; Jones G; Ple P Drug Metab Dispos; 1997 Mar; 25(3):367-70. PubMed ID: 9172956 [TBL] [Abstract][Full Text] [Related]
16. Preliminary report of the distribution of [14C]penicillic acid in rats: autoradiographic technique. Park DL; Miller E; Heath JL Am J Vet Res; 1978 Nov; 39(11):1863-5. PubMed ID: 736347 [TBL] [Abstract][Full Text] [Related]
17. A spectrophotometric method for the estimation of the carcinostatic agent, 5-aziridino-2,4-dinitrobenzamide (CB 1954), in biological fluids. Ross WC Biochem Pharmacol; 1969 Oct; 18(10):2683-8. PubMed ID: 5404002 [No Abstract] [Full Text] [Related]
18. Pharmacokinetics of the protein antitumor antibiotic neocarzinostatin after bolus injection in humans. Comis RL; Griffin TW; Raso V; Ginsberg SJ Cancer Res; 1979 Mar; 39(3):757-61. PubMed ID: 154969 [No Abstract] [Full Text] [Related]
19. ORAL ADMINISTRATION OF VINBLASTINE SULFATE (NSC-49842) TO CANCER PATIENTS. KORST DR; NIXON JC Cancer Chemother Rep; 1965 Apr; 45():53-6. PubMed ID: 14328049 [No Abstract] [Full Text] [Related]
20. A micellar electrokinetic capillary chromatography method for monitoring mycophenolic acid in serum of transplant recipients. Suntornsuk L; Meyer T; Lindgren A; Frahm AW Pharmazie; 2005 Feb; 60(2):115-9. PubMed ID: 15739899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]